This text is a result of machine translation.
Hecheng Co., Ltd.: the abbreviation of the company's securities is proposed to be changed to "Jianfa Hecheng"
Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum
A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.
May 18, 2026 02:22 PM
Sino Biopharm and Boehringer Ingelheim Sign Option and License Deal for Six Cancer Programs
Sino Biopharmaceutical(中国生物制药)and Boehringer Ingelheim(勃林格殷格翰)announced an option and license agreement on November 4 covering six preclinical cancer programs. Sino Biopharm will receive USD 358 million in upfront and near-term payments and may receive up to USD 7 billion in additional option, development, regulatory and commercial milestone payments.
Nov 05, 2026 11:22 AM
Wantai Launches Nine-Valent HPV Vaccine Cecolin 9 in Thailand
Wantai Biological(万泰生物)said on November 2 that its nine-valent HPV vaccine, Cecolin 9(馨可宁9), had launched in Thailand. The product was jointly developed by its subsidiary Xiamen Innovax Biotech(厦门万泰沧海生物技术有限公司)and Xiamen University(厦门大学).
Nov 03, 2026 11:19 AM
Great wall holding Weishi energy completed the round a financing of RMB 900 million, and the post investment valuation exceeded RMB 4 billion
Futurtec Adds CE MDR-Certified Knee-Replacement System to Its Orthopedic Robotics Portfolio
Futurtec(鑫君特)has received European Union Medical Device Regulation certification for its ORTHBOT X knee-replacement surgical navigation and positioning system, according to a company announcement reported by MedChina in August.
Aug 27, 2026 03:47 PM
Kanghong’s Conbercept Receives Marketing Authorization in Guyana
Kanghong Pharmaceutical (康弘药业) said its subsidiary Kanghong Bioscience had received a drug registration certificate from Guyana’s Food and Drug Department for conbercept ophthalmic injection, marketed under the brand name Lumitin (朗沐).
Aug 20, 2026 02:48 PM
Global Expansion Fuels BYD's Profit Recovery Above RMB 10 Billion
Updated 4 hours ago
Disruptive Competitiveness: The Missing Piece in the Sovereignty Puzzle
Updated 9 hours ago
Revenue Up 283%, Over 60% From Overseas: MiniMax's Global Expansion
Nov 05, 2026 08:41 PM
How BYD Is Turning China's EV Advantages into Global Growth
Nov 05, 2026 08:35 PM